You are here: Industry Insights > Kymera

News List

Kymera Therapeutics Appoints Elaine Caughey as Chief Business Officer firstwordpharma
June 22, 2021
today announced the appointment of Elaine Caughey, MBA, as Chief Business Officer. Ms. Caughey joins Kymera with over 20 years of experience in the biotechnology industry, including leadership roles in corporate development, business.
Kymera, Sanofi Enter Multi-program Strategic Alliance contractpharma
July 10, 2020
To develop and commercialize first-in-class protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases.
Vertex and Kymera to identify protein degradation therapeutics pharmaceutical-technology
May 22, 2019
Vertex Pharmaceuticals and Kymera Therapeutics have formed a strategic research and development (R&D) alliance to develop protein degradation medicines for various targets.
GSK and Kymera team up for protein degradation alliance pharmatimes
July 18, 2018
GlaxoSmithKline and Kymera have sealed a pact to work together on the discovery of new medicines based on protein degradation.